Alpha Genesis

Alpha Genesis

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Alpha Genesis, Inc. positions itself as America's premier primate research center, offering an integrated suite of services to de-risk and accelerate therapeutic development. With decades of experience and over 100 acres of dedicated facilities, the company combines world-class animal care, state-of-the-art surgical and laboratory platforms, and deep regulatory expertise to generate reproducible data for regulatory submissions. AGI's mission is to accelerate breakthroughs in human and animal health by providing reliable, translational NHP solutions while upholding the highest standards of animal welfare and biosecurity.

Broad Spectrum Preclinical SupportImmunologyMetabolic DiseaseGene TherapyNeuroscienceOphthalmologyOrthopedicsRare Disease

Technology Platform

Integrated nonhuman primate research ecosystem comprising large-scale specific-pathogen-free (SPF) breeding colonies, GLP-compliant BSL-2 laboratories and surgical suites, CDC-approved quarantine, and a biological materials bank, all operating under AAALAC-accredited animal welfare standards.

Opportunities

AGI is poised for growth due to increasing global demand for nonhuman primates in complex drug development, particularly for cell/gene therapies and biologics.
Opportunities include expanding its specialized service offerings in high-growth areas like gene therapy models and forming strategic, long-term partnerships with large biopharma sponsors.
Leveraging its vast colony data for analytics and insights presents an additional value-creation avenue.

Risk Factors

Key risks include intense regulatory and public scrutiny over animal research, potential biosecurity outbreaks that could devastate its primate colonies, and competitive pressure from international breeders and larger CROs.
Dependency on a stable regulatory environment for animal imports and use is also a significant ongoing challenge.

Competitive Landscape

AGI competes with large, diversified CROs (e.g., Charles River, Labcorp), specialized primate research centers, and international breeding facilities. Its primary differentiation lies in its vertical integration as the largest U.S. breeder with full-service CRO capabilities, offering supply security, consistency, and a strong ethical stance that appeals to sponsors navigating complex regulatory pathways.